Ning-Ping Wang Selected Research

Ning-Ping Wang Research Topics

Disease

12	Fibrosis (Cirrhosis) 07/2022 - 12/2012
10	Ischemia 01/2015 - 09/2004
9	Myocardial Infarction 01/2017 - 02/2004
8	Infarction (Infarctions) 04/2014 - 07/2003
4	Cicatrix (Scar) 01/2015 - 11/2008
4	Hypoxia (Hypoxemia) 09/2008 - 04/2005
3	Hypertension (High Blood Pressure) 07/2022 - 05/2016
3	Heart Failure 01/2019 - 01/2015
2	Mitochondrial Diseases (Mitochondrial Disease) 07/2022 - 09/2008
2	Reperfusion Injury 02/2010 - 08/2003
1	Hypertrophy 02/2020
1	Inflammation (Inflammations) 08/2011
1	Coronary Occlusion 09/2006
1	Necrosis 06/2006

Drug/Important Bio-Agent (IBA)

11	Angiotensin IIIBA 07/2022 - 01/2015
11	CollagenIBA 02/2020 - 12/2012
4	CurcuminIBA 01/2015 - 12/2012
3	Glucagon-Like Peptide 1 (GLP 1)IBA 07/2022 - 06/2015
3	Liraglutide FDA Link 01/2020 - 06/2015
3	Angiotensin-Converting Enzyme 2IBA 01/2017 - 01/2015
3	Oxidants (Oxidizing Agents)IBA 06/2008 - 09/2004
3	Creatine Kinase (Creatine Phosphokinase)IBA 04/2004 - 07/2003
2	Proteins (Proteins, Gene)FDA Link 02/2020 - 09/2008
2	LinagliptinIBA 01/2020 - 06/2015
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2019 - 06/2015
2	Matrix Metalloproteinases (MMPs)IBA 01/2013 - 12/2012
2	Malondialdehyde (Propanedial)IBA 12/2012 - 04/2005
2	Adenosine (Adenocard)FDA LinkGeneric 11/2008 - 01/2004
2	AntioxidantsIBA 06/2008 - 09/2006
2	Acetylcysteine (Siran)FDA LinkGeneric 06/2008 - 09/2006
2	salicylhydroxamic acid (SHAM)IBA 09/2006 - 04/2005
2	Phosphotransferases (Kinase)IBA 09/2006 - 09/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2006 - 09/2006
2	Apoptosis Regulatory ProteinsIBA 09/2006 - 06/2006
1	NADPH Oxidases (NAD(P)H oxidase)IBA 07/2022
1	steroidogenic acute regulatory proteinIBA 02/2020
1	AldosteroneIBA 02/2020
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 02/2020
1	Telmisartan (Micardis)FDA Link 02/2020
1	Spironolactone (Aldactone)FDA LinkGeneric 02/2020
1	Pharmaceutical PreparationsIBA 01/2019
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 04/2017
1	AngiotensinsIBA 06/2015
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2015
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2015
1	triphenyltetrazoliumIBA 04/2014
1	S 10 (S-10)IBA 04/2014
1	mitochondrial K(ATP) channelIBA 01/2013
1	5-hydroxydecanoic acidIBA 01/2013
1	1- (5- Isoquinolinesulfonyl)- 2- Methylpiperazine (H 7)IBA 01/2013
1	Hemostatics (Antihemorrhagics)IBA 08/2011
1	EmulsionsIBA 03/2010
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 02/2010
1	Protein Kinase CIBA 02/2010
1	Vasodilator Agents (Vasodilators)IBA 11/2008
1	von Willebrand FactorIBA 11/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2008
1	Mitochondrial Permeability Transition PoreIBA 09/2008
1	fluorexon (calcein)IBA 09/2008
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 09/2008
1	Adenosine Triphosphate (ATP)IBA 09/2008
1	CytokinesIBA 06/2008
1	CaspasesIBA 09/2006
1	Caspase 3 (Caspase-3)IBA 09/2006
1	Transcription Factors (Transcription Factor)IBA 06/2006
1	cobaltous chloride (cobalt(II)chloride)IBA 06/2006
1	Deferoxamine (Desferal)FDA LinkGeneric 06/2006
1	Cytochromes c (Cytochrome c)IBA 04/2005
1	10,10'-dimethyl-9,9'-biacridinium (Lucigenin)IBA 04/2005
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 04/2005
1	GTP-Binding Proteins (G-Protein)IBA 04/2004
1	Sodium-Hydrogen ExchangersIBA 02/2004
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2004
1	EndonucleasesIBA 07/2003
1	Aurintricarboxylic AcidIBA 07/2003

Therapy/Procedure

3	Therapeutics 06/2015 - 09/2006
2	Transplantation 02/2010 - 11/2008
1	Adrenalectomy 02/2020
1	Operative Surgical Procedures 08/2011
1	Intravenous Infusions 11/2008
1	Ligation 09/2006
1	Deep Hypothermia Induced Circulatory Arrest 06/2006
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 08/2003
1	Organ Transplantation 08/2003